Bharat Immunologicals & Biologicals (BOM:524663) Other Current Liabilities: ₹274.12 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524663 Bharat Immunologicals & Biologicals Corp Ltd BOM:524663
4 GF Score
Price ₹15.86
View Full Analysis

What is Bharat Immunologicals & Biologicals Other Current Liabilities?

Bharat Immunologicals & Biologicals BOM:524663 -0.63% 4 Other Current Liabilities is ₹274.12 Mil as of Sep. 2023. GuruFocus rates BOM:524663 with a GF Score™ of 4/100.

Bharat Immunologicals & Biologicals's other current liabilities for the quarter that ended in Sep. 2023 was ₹274.12 Mil.

Bharat Immunologicals & Biologicals's quarterly other current liabilities declined from Mar. 2023 (₹199.37 Mil) to Jun. 2023 (₹0.00 Mil) but then increased from Jun. 2023 (₹0.00 Mil) to Sep. 2023 (₹274.12 Mil).

Bharat Immunologicals & Biologicals's annual other current liabilities increased from Mar. 2021 (₹177.45 Mil) to Mar. 2022 (₹205.59 Mil) but then declined from Mar. 2022 (₹205.59 Mil) to Mar. 2023 (₹199.37 Mil).

Bharat Immunologicals & Biologicals Other Current Liabilities Related Terms

Bharat Immunologicals & Biologicals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Bharat Immunologicals & Biologicals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bharat Immunologicals & Biologicals Other Current Liabilities Chart

Bharat Immunologicals & Biologicals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.88 517.41 177.45 205.59 199.37

Bharat Immunologicals & Biologicals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 203.26 0.00 199.37 0.00 274.12
BOM:524663
4GF Score
Bharat Immunologicals & Biologicals Corp Ltd BOM:524663
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bharat Immunologicals & Biologicals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₹274.12 Mil mean?
Bharat Immunologicals & Biologicals (BOM:524663) has a Other Current Liabilities of ₹274.12 Mil as of Sep. 2023. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bharat Immunologicals & Biologicals.
Is Bharat Immunologicals & Biologicals' Other Current Liabilities too high?
Bharat Immunologicals & Biologicals' current Other Current Liabilities is ₹274.12 Mil. Overall, Bharat Immunologicals & Biologicals has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Bharat Immunologicals & Biologicals' Other Current Liabilities compare to VRTX and REGN?
Bharat Immunologicals & Biologicals' Other Current Liabilities of ₹274.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bharat Immunologicals & Biologicals. Bharat Immunologicals & Biologicals's current Other Current Liabilities is ₹274.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bharat Immunologicals & Biologicals stock overvalued right now?
Bharat Immunologicals & Biologicals (BOM:524663) has a current Other Current Liabilities of ₹274.12 Mil. The current Other Current Liabilities is ₹274.12 Mil. Bharat Immunologicals & Biologicals' overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Bharat Immunologicals & Biologicals (BOM:524663), the current Other Current Liabilities is ₹274.12 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bharat Immunologicals & Biologicals Business Description

Address Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.
4GF Score

Get the complete analysis for BOM:524663

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.86
Price